A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF

In situ gene therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF) was demonstrated to successfully inhibit tumour cell growth in a mouse orthotopic bladder cancer model, but suffered from several disadvantages, such as limited efficiency for gene delivery, low expression efficiency...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhiming, Tan, Wanlong, Zhang, Lin, Liang, Zhongkun, Xu, Cuixiang, Su, Hua, Lu, Jianxin, Gao, Jimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829043/
https://www.ncbi.nlm.nih.gov/pubmed/19627402
http://dx.doi.org/10.1111/j.1582-4934.2009.00818.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829043/
https://www.ncbi.nlm.nih.gov/pubmed/19627402
http://dx.doi.org/10.1111/j.1582-4934.2009.00818.x

Ejemplares similares